首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1738460

細胞冷凍保存市場（按產品類型、應用、最終用戶和地區分類）

Cell Cryopreservation Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年04月29日 | 出版商:

Coherent Market Insights | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年細胞冷凍保存市場規模將達到 124.4 億美元，到 2032 年將達到 536.4 億美元，2025 年至 2032 年的複合年成長率為 23.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	124.4億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	23.20%	2032年價值預測	536.4億美元

圖。 2025年各地區細胞冷凍保存市場佔有率（%）

細胞冷凍保存是指使用液態氮將細胞冷卻至極低溫度（通常低於-80°C）來保存細胞。細胞可以保存很久而不會影響其活力。癌症和遺傳疾病發生率的上升，以及對再生醫學研究、幹細胞庫、生育治療和組織工程的投資增加等因素，可能會推動研究機構和醫院對細胞冷凍保存過程的需求。冷凍保存設備和解決方案的技術進步也將促進市場成長。然而，在預測期內，冷凍保存程序和設備的高成本可能會阻礙市場成長。

市場動態：

全球細胞冷凍保存市場成長的主要驅動力是慢性病和危及生命的疾病盛行率的上升。全球癌症和遺傳疾病的流行推動了對嚴重依賴冷凍保存細胞的研究活動、細胞療法和臨床試驗的需求。根據世界癌症研究基金會的數據，2020 年全球報告了約 1,800 萬例新癌症病例。此外，公共和私營部門對再生醫學、幹細胞研究和醫學生物技術創新的投資不斷增加，也促進了冷凍保存流程的普及。然而，冷凍保存設備、液態氮和整體程序的高成本可能會阻礙市場成長。此外，熟練專業人員的短缺和耗時的冷凍過程中的技術挑戰可能會阻礙市場成長。機器人冷凍保存技術和設備的不斷發展可能會提供有利可圖的市場成長機會。

本研究的主要特點

本報告對全球細胞冷凍保存市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球細胞冷凍保存市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球細胞冷凍保存市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球細胞冷凍保存市場的各種策略矩陣來促進決策。

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Lonza Group Ltd.
- STEMCELL Technologies Inc.
- BioLife Solutions, Inc.
- Cryolife, Inc.
- Organ Recovery Systems Inc.
- Custom Biogenic Systems
- Sartorius AG
- Takara Bio Inc.
- Chart Industries, Inc.
- Biocision, LLC
- Cardinal Health, Inc.
- Helmer Scientific

第10章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1698

Cell Cryopreservation Market is estimated to be valued at USD 12.44 Bn in 2025 and is expected to reach USD 53.64 Bn by 2032, growing at a compound annual growth rate (CAGR) of 23.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 12.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	23.20%	2032 Value Projection:	USD 53.64 Bn

Figure. Cell Cryopreservation Market Share (%), By Region 2025

Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.

Market Dynamics:

Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2020. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global cell cryopreservation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Nippon Genetics, Miltenyi Biotec, Mediatech, Inc., Genzyme Corporation, BioLifeSolutions, Inc., VWR International, LLC, and BiolifeSolutions, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market

Detailed Segmentation-

By Product Type
- Cryoprotectant Agents
- Glycerol
- Dimethyl Sulfoxide (DMSO)
- Others
- Equipment
- Incubators
- Liquid Nitrogen Supply Tanks
- Freezers
- Others
By Application
- Stem Cells
- Oocytes and Embryotic cells
- Sperm Cells
- Hepatocytes
- Others
By End User
- Biopharmaceutical & Pharmaceutical Companies
- Research Institutes
- Biobanks
- IVF clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Lonza Group Ltd.
- STEMCELL Technologies Inc.
- BioLife Solutions, Inc.
- Cryolife, Inc.
- Organ Recovery Systems Inc.
- Custom Biogenic Systems
- Sartorius AG
- Takara Bio Inc.
- Chart Industries, Inc.
- Biocision, LLC
- Cardinal Health, Inc.
- Helmer Scientific

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Cell Cryopreservation Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Cell Cryopreservation Market, By Product Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cryoprotectant Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Glycerol
  - Dimethyl Sulfoxide (DMSO)
  - Others
Equipment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Incubators
  - Liquid Nitrogen Supply Tanks
  - Freezers
  - Others

6. Global Cell Cryopreservation Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oocytes and Embryotic cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sperm Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatocytes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Cryopreservation Market, By End User, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical & Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biobanks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
IVF clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Cryopreservation Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GE Healthcare
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lonza Group Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- STEMCELL Technologies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioLife Solutions, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cryolife, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Organ Recovery Systems Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Custom Biogenic Systems
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sartorius AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takara Bio Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Chart Industries, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biocision, LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cardinal Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Helmer Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies